Cargando…
SGLT2 inhibitors: An answer to diabetes or a question to its complications?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213700/ https://www.ncbi.nlm.nih.gov/pubmed/35757315 http://dx.doi.org/10.1016/j.amsu.2022.103992 |
_version_ | 1784730893983678464 |
---|---|
author | Priya Kumar, Ayush Khatri, Govinda Hasan, Mohammad Mehedi |
author_facet | Priya Kumar, Ayush Khatri, Govinda Hasan, Mohammad Mehedi |
author_sort | Priya |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9213700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-92137002022-06-23 SGLT2 inhibitors: An answer to diabetes or a question to its complications? Priya Kumar, Ayush Khatri, Govinda Hasan, Mohammad Mehedi Ann Med Surg (Lond) Correspondence Elsevier 2022-06-13 /pmc/articles/PMC9213700/ /pubmed/35757315 http://dx.doi.org/10.1016/j.amsu.2022.103992 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Correspondence Priya Kumar, Ayush Khatri, Govinda Hasan, Mohammad Mehedi SGLT2 inhibitors: An answer to diabetes or a question to its complications? |
title | SGLT2 inhibitors: An answer to diabetes or a question to its complications? |
title_full | SGLT2 inhibitors: An answer to diabetes or a question to its complications? |
title_fullStr | SGLT2 inhibitors: An answer to diabetes or a question to its complications? |
title_full_unstemmed | SGLT2 inhibitors: An answer to diabetes or a question to its complications? |
title_short | SGLT2 inhibitors: An answer to diabetes or a question to its complications? |
title_sort | sglt2 inhibitors: an answer to diabetes or a question to its complications? |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213700/ https://www.ncbi.nlm.nih.gov/pubmed/35757315 http://dx.doi.org/10.1016/j.amsu.2022.103992 |
work_keys_str_mv | AT priya sglt2inhibitorsananswertodiabetesoraquestiontoitscomplications AT kumarayush sglt2inhibitorsananswertodiabetesoraquestiontoitscomplications AT khatrigovinda sglt2inhibitorsananswertodiabetesoraquestiontoitscomplications AT hasanmohammadmehedi sglt2inhibitorsananswertodiabetesoraquestiontoitscomplications |